Tetrahedron Letters,Vol.25,No.ll,pp Printed in Great Britain
ASYMMETRIC and
Research
Morooka,
Summary:
Asymmetric
butyric
acid,
of chiral
Phosphorus active
derivative strong
analogues
with
Hirayama
of
has been
to vinyl
of glutamic
Thus,
Seika
Fukatsu
Kaisha
Ltd.,
222, Japan
(+)-phosphinothricin,
enantiomers bases
ACID
and Shunzo
Meiji
Yokohama
Kohoku-ku,
(+)-2-amino-4-phosphono-
achieved
phosphorus
by the Michael
addition
compounds.
acid are interesting
(+)-phosphinothricin
((S)-(+)-l)
as biologically and its alanylalanine
(2), produced by two strains of Streptomyces, 1) have activity. 2) (+)-2-Amino-4-phosphonobutyric acid ((S)-(+)-A)
glutamate
an antiviral
for receptors activity. 3)
We have
recently
reported
the Michael
addition
of glycine
extention
(+)-PHOSPHINOTHRICIN
(bialaphos)
herbicidal
competes have
Schiff
substances.
OF
Laboratories,
synthesis
and their
glycine
SYNTHESIS
oo40-4039/84 $3.00 + -00 01984 Pergamon Press Ltd.
(+)-2-AMINO-4-PHOSPHONOBUTYRIC Minowa, * Masao
Nobuto Central
1147-1150,1984
of the preceding
in nerve
a practical Schiff
study,
cells,
synthesis
base
and has been
reported
to
of
(+)-phosphinothricin by 4) As an (4a). an effective asymmetric synthe-
to vinylphosphinate
we now report
sis of 1 and -3. According to this method, both of the S- and R-enantiomers can be prepared by the asymmetric Michael addition of chiral Schiff bases (S)5) to vinyl with
phosphorus chiral
chiral
Scheme
compounds
4a and 4b. Although a number of asymmetric reactions _. has been reported,b) there have been a few examples using 7) donors .
acceptors
Michael
1
R1 0 '&CH=CH~ R2'
4a: R1=Me, R2=Me0 , 9 4b: RI=R'=EtO -
NCH2COOEt
+
(-)-5:
(lS,2S,5S)
1147
(S)-(+)-1:
Rt=M;,
R2=OH
(S)-(+)-3:
R-=R-=OH
1148
Table
1.
Asymmetric
Michael
Addition
Additive
donor
1
4a -
(-,-I
2
4a 4a -
(+)-2 ;
4a 4b -
(-)-!j 18-crown-6d)
L
c-,-s
3
5 6
(+I-?
7 8
CH2=CHCOOMe
(+I-5
(-)-S
reactions
c 1.0 in H20.
were
was
3. g) Based
tical
purity
vinyl
(S) [851
-12.4b)
73c)
(R) [881
,":
+7.6b)
45')
(S) [481
51
+6.8b)
4oc)
(S) [431
-3 -3
68
+14.6e)
5of)
(S) [541
65
-13,oe)
45f)
(RI [541
-7 1
57
-17.7e)
56g)
(RI t6ll
55
+14.9e)
47')
(S) [581
e) c 1.0 in 6N-HCl. of
Michael
addition
was
solution
was
the residue propylene sulting
oxide solution
to give
Treatment Schiff
base
acid was
for 24 hr.
dissolved was was
under
in
for the op-
After
yellow
and purified
The results
C-)-S, obtained
') afforded
the desired acid
and the
and the solution,
amount
for 1 hr. resin
in Table
(4a) and vinylphosphonate by the condensation of glycine
(+1-l) and (+)-2-amino-4-phosphonobutyric high optical purities (entries 1 and 5).
acid
by ion-exchange
are summarized
of vinylphosphinate
25, 5S)-2-hydroxypinan-3-one,
solution
excess
at 25OC
of
The re-
(Dowex
1.
(4b) with the chiral ethyl ester and (lS,
(+)-phosphinothricin
c(S)-(+I-?),
On the other
of
for 1 hr at
of the resulting
stirred
The
of a solution
(1:l) and a large was
1.
t-butoxide of the chiral
stirred
6N hydrochloric
concentration
The solution
acid.
a solution
argon.
added
in Scheme
of potassium
by addition
to the resulting was
After
concentrated
added
followed
in ethanol-water
added.
the amino
[a]D +29'(6N-HCl)
as shown
solution
(THF) was
added
To the residue
refluxed was
on
acid. h) Corrected
undertaken
To a stirred
(2.0 eq) in tetrahydrofuran
was removed.
of t-BuOK. b) equivalents
8. d) Five
see: ref. 9.
is as follows.
1N hydrochloric
two equivalents in ref.
f) Based
(+)-glutamic
5 (1.0 eq) in THF at -78'C, compound (1.0 eq) in THF at -78V
solvent
using
1.0 , H20)
base
-78'C,
50X2)
79C’
out at -78'C
[al, +31.4"
a) (5) -
Bases
Optical purity (%),) (Confign.) ,[Calcd.l
[ali5,deg.
66
[al, 23 +17O(c
of the ketol,
procedure
(t-BuOK) Schiff
on
used.
on
The asymmetric general
carried
c) Based
of the additive ref.
HMPAd)
Schiff
+13.4b)
1 -
c-,-s
4b CH2=CHCOOMe
a) All
Glycine
acid-,
Compd. Total no. yield(%)
acceptor
4
Chiral
/-Amino
/-MichaelEntry
using
hand,
respectively, the reactions
t(S)in of
4a and 4b with the other chiral Schiff base (+)-I, similarly prepared from (lR, 9) gave their enantiomers, 2R, 5R)-2-hydroxypinan-3-one, (-)-phosphinothricin (CR)-(-j-l) in high
from which sources,
and
optical
(-)-2-amino-4-phosphonobutyric purities
the chiral
the present
(-)-isomers
(entries
ketols method
2 and 6).
are prepared, has
of 1 and 2 in high
advantage optical
acid Since
((R)-(-)-3), both
are readily in providing
purities.
respectively,
enantiomers available both
of a-pinene,
from natural
(S)-(+)-
and
CR)-
1149
In order phorus
to clarify
the high
the following
compounds,
chiral
induction
studies
were
observed
carried
for the vinyl
out.
Addition
of
phos-
(-1-5
to 4a in the presence of hexamethylphosphoric triamide (HMPA) or dicyclohexyl10) gave 18-crown-6 (18-crown-61, which has strong ability to solvate cations, lower
optical
purity
may be explained
of the product
(S)-(+)-l
(entries
These
3 and 4).
results
intermediate as shown in Fig. 11) and Koga et al. 12) 1, which is similar to those proposed by Meyers et al. --It is assumed that the coordination of the electron pairs on the nitrogen atom and the oxygen plays
ment
by the existence
atom of phosphoryl
a central of
role
C-)-S and
(-)-I) and the
7 and 8). course
(+)-2 with
(+)-isomer
That
studies
methyl
yields
of potassium
(5) gave
alkoxide
Interestingly,
addition.
acrylate
t(S)-(+)-I),
(-)-glutamic
treat-
acid
((R)-
re-
(entries
of 2 to methyl
the same as that of alkylation
of 2 and opposite to vinyl
to the potassium
orientated
is, the stereochemical
of the addition
late was
group
in this highly
in good optical
spectively,
of the chelate
'0
acry5)
‘!
to that of the addition
phosphorus
compounds.
on the detailed
4
6 11
Further
mechanism
?v0;
&
*P
Fig.1
are now
/ ‘R2
R’
in progress. The herbicidal (*)-l_ and
activity
(R)-(-)-l
and Professor
of Tokyo,
for their
valuable
References
(S)-(+1-l_ was
advice
remarkably
stronger
than those of
treatment.
We are grateful
Acknowledgment: versity
of
in foliage
to Professor
Kikumasa
throughout
Sato,
Teruaki
Yokohama
Mukaiyama,
National
The Uni-
University,
this work.
and Notes --
1) E. Bayel,
K. H. Gugel,
and H. Zahner, Ogawa,
Helv.
T. Turuoka,
Yoshida,
K. Hagele,
Chim.
Acta,
H. Watanabe,
S. Inouye,
H. Hagenmaier, E,
224
K. Totsukawa,
and T. Niida,
S. Jessipow,
(1972);
Y. Kondo,
T. Suzuki,
Sci. Reports
of Meiji
W. A. Ke)nich, T. Shomura,
C. Moriyama, Seika
Y.
J.
Kaisha,
1973,
34. 2)
K. Tachibana,
T. Watanabe,
Seika
1980,
Kaisha,
Felcht,
Angew.
3) S. G. Cull-Candy, 1976,
408;
4) N. Minowa, 24,
2391
and Y. Sekizawa,
K. Weissermel,
Int. Ed. Engl.,
J. F. Donnellan,
J. F. Koerner S. Fukatsu,
H. J. Kleiner,
20,
223
M. Takada,
Reports
M. Finke,
of Meiji
and U. H.
(1981).
R. W. James,
and C. W. Cotman,
T. Niida,
Sci.
and G. G. Lunt,
Brain
Research,
and K. Sato,
216,
Nature, 192
Tetrahedron
(1981). Lett.,
(1983).
5) S. Yamada, T. Oguri, (1978);
27;
Chem.
Y. Suzuki,
T. Oguri, N. Kawai,
and T. Shioiri, T. Shioiri,
J. A. Bajgrowicz,
Viallefont,
Tetrahedron
J. Chem.
B. Cossec,
Lett.,
Sot. Chem.
and S. Yamada,
24,
Chem.
Ch. Pigiere,
3721
(1983).
Comm.,
Pharm.
1976,
Bull.,
R. Jacquier,
136;
2,
and Ph.
803
1150
6) A. I. Meyers,
and C. E. Whitten,
Hashimoto,
S. Yamada,
Hashimoto,
N. Komeshima,
T. Mukaiyama,
and K. Koga,
T. Takeda,
S. Inoue,
and K. Ogura, K. Miura,
T. Hoshiko,
and M. Hulce,
Tetrahedron
and C. Ullenius,
8) Y. Ogawa,
T. Tsuruoka,
Kaisha,
42.
1913,
9) According
2.64,
(neat) and the
10) HMPA:
were
Chem.
Lett.,
1981,
797.
Lett., 1978,
11) A. I. Meyers, 567
estimated
(1976).
Tetrahedron
[ali
R. H. Mueller,
Crown
Sci. Reports
[J. Org.
-37.O"(c from
92.5%
G. W. Gokel,
1976,
653;
T. Mukaiyama,
461;
T. Takeda,
K. Kamata,
M.
Chem.,
36,
2.60, CHC13)
of the
and 82.59,
Y. Hirako,
[lit.5)
[a], 22 +47.1° from
(S)- and
respectively.5)
J. Am. Chem.
Sot.,
and N. W. Rebert,
and T. Takeda,
and T. Mukaiyama,
and M. E. Ford,
Seika
2319
was obtained
H. M. Gerdes,
T. Hoshiko,
of Meiji
(+)-c-pinene,
and A. K. Willard,
ether:
G. Knaus,
M. Iijima,
(1982).
was prepared
to be at least
T. Takeda,
H. Malmberg,
(R)-isomer, [ali +33.0°(c 2.60, CHC13), 22 -42.0°(neat). The optical purities
R. E. Ireland,
98, 2868
3823
J. P.
(1981). 461;
K. Yamamoto,
(1982) ;
T.
S. Mitamura,
53, 2307
[a],
(-)-a-pinene, (R)-ketols
CHC13)],
797;
3711
and Pierce
(S)-2-hydroxypinan-3-one,
-38.9“(c
[ali
1981,
S.
(1979);
1165;
1978,
S.
(1979);
2437
G. Posner,
Lett.,
and T. Niida,
of Carlson
21,
1977,
323;
Chem.,
Chem.
2,
23,
S. Inouye,
to the method
(1971) 1,
ibid.,
1973,
(1975);
z_Z, 771
G. Tsuchihashi,
Pure Appl.
ibid.,
ibid.,
Lett.,
Lett.,
Lett.,
Bull.,
913;
and T. Takeda,
and T. Mukaiyama,
Pharm.
6266
Chem.
1981,
Tetrahedron
Y. Hirako,
and Y. Ogimura, Nilsson,
ibid.,
97,
Sot.,
and K. Koga,
and M. Osaki,
and N. Iwasawa,
Mallamo,
Chem.
S. Yamada,
Mukaiyama
7) T. Mukaiyama,
J. Am. Chem.
J. Am. Chem.
ibid.,
Sot.,
98,
(1976).
12) S. Hashimoto K. Koga, (Received
and K. Koga,
Chem.
Pharm.
in Japan
Tetrahedron
Bull.,
10 December
27,
2760
1983)
Lett., (1979).
1978,
573;
S. Hashimoto
and